Cellebrite DI (CLBT) Revenue (2020 - 2025)

Cellebrite DI's Revenue history runs 6 years deep, the most recent figure standing at $128.8 million for Q4 2025.

• On a quarterly basis, Revenue rose 18.13% year-over-year to $128.8 million in Q4 2025; TTM through Dec 2025 was $475.7 million, a 18.56% increase from a year earlier, with the FY2025 full-year figure at $475.7 million, up 18.56% from the prior year.
• Revenue rose to $128.8 million in Q4 2025 per CLBT's latest filing, from $126.0 million in the prior quarter.
• Across five years, Revenue topped out at $128.8 million in Q4 2025 and bottomed at $53.3 million in Q1 2021.
• The 5-year median for Revenue is $80.4 million (2023), against an average of $85.9 million.
• Across the five-year window, Revenue gained 5.75% in 2022 and advanced 26.94% in 2024, its largest moves.
• Year by year, Revenue stood at $67.9 million in 2021, then increased by 9.0% to $74.0 million in 2022, then increased by 25.66% to $93.0 million in 2023, then grew by 17.24% to $109.0 million in 2024, then climbed by 18.13% to $128.8 million in 2025.
• Per Business Quant, the three latest CLBT Revenue figures stand at $128.8 million (Q4 2025), $126.0 million (Q3 2025), and $113.3 million (Q2 2025).